Trustee

Fred Dotzler is a managing director and co-founder of De Novo Ventures, a firm that invests in medical devices and biotechnology. Previously he was a managing general partner of Medicus Venture Partners, a general partner with Crosspoint Venture Partners, and an executive in finance, marketing, sales, manufacturing, and business development for a variety of medical, technology, and biotech companies.
 

Mr. Dotzler earned an MBA from the University of Chicago, a masters equivalent in economics from the University of Louvain, Belgium, and a B.S. in engineering from Iowa State University. He is a member of the advisory board of the Journal of Private Equity and a trustee of the Salk Institute.